Delivery Order SPE2DB20D1004-SPE2DB22FF8Y0
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,190.47 firm fixed-price delivery order is for GRALISE ER 600 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.78, is a firm fixed-price Delivery Order for the medical product GRALISE ER 600 MG TABLET 90S. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,799.72 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication product. The contract, which has a period of performance ending on July 30, 2024, does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous contracts by various...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,710.75 Delivery Order contract is for the supply of the prescription medication GRALISE ER 600 MG TABLETS in quantities of 90. The contract has a firm fixed price and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- This federal contract award, valued at $1,873.20, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period through March 13, 2024. This contract award does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- This federal contract award, valued at $4,161.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GRALISE ER 600 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a completion date of December 12, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,189.30, is a firm fixed-price delivery order for the provision of 4564931397 GRALISE ER 300 MG TABLET 90S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,213.96 contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication, with a completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,375.08 firm fixed-price contract is for the supply of GRALISE ER 600 MG tablets. The award is not associated with a set-aside program. AmerisourceBergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,047.48 Firm Fixed Price Delivery Order covers the supply of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product, with a period of performance through October 28, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF8Y0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,409.34 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a medication. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/11/22 |